当前位置: X-MOL首页全球导师 海外导师 › Gelber, Allan

个人简介

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, as well as to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to 2nd year medical students at Johns Hopkins and taught (2013, 2014) at the Perdana University Graduate School of Medicine in Kuala Lumpur, Malaysia. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. MD, Johns Hopkins University School of Medicine (1989)

研究领域

Clinical Epidemiology of the Rheumatic Disorders

Dr. Gelber’s research activity applies the tools of clinical epidemiology across the spectrum of rheumatic disorders. His investigative pursuits include recent studies identifying predictors of prevalent and incident gout, autoantibodies in primary and secondary Sjogren’s syndrome, predictors of outcomes in scleroderma, and cardiovascular disease burden and risk in rheumatoid arthritis.

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Maynard JW, McAdams-Demarco MA, Law A, Kao L, Gelber AC, Coresh J, Baer AN. Racial Differences in Gout Incidence in a Population-Based Cohort: Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2013 Dec 13. [Epub ahead of print] PMID: 24335384 [PubMed - as supplied by publisher] Chung CP, Giles JT, Kronmal RA, Post WS, Gelber AC, Petri M, Szklo M, Detrano R, Budoff MJ, Blumenthal RS, Ouyang P, Bush D, Bathon JM. Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther. 2013 Sep 25;15(5):R134. doi: 10.1186/ar4314. PMID: 24286380 [PubMed - in process] Mahoney K, Cayea D, Li QK, Gelber AC. A Handy Clue: Palmar Fasciitis and Polyarthritis Syndrome. Am J Med. 2013 Oct 8. pii: S0002-9343(13)00845-0. doi: 10.1016/j.amjmed.2013.09.021. [Epub ahead of print] No abstract available. PMID: 24262804 Juraschek SP, Kurano T, Rosen A, Gelber AC. Acute gout after renal transplantation with notable hypouricemia. Am J Med. 2013 Oct;126(10):e5-6. PMID:23891284 Gelber AC, Manno RL, Shah AA, Woods A, Le EN, Boin F, Hummers LK, Wigley FM. Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature. Medicine (Baltimore). 2013 Jul;92(4):191-205. PMID: 23793108 Park JK, Gelber AC, George M, Danoff SK, Qubti MA, Christopher-Stine L. Pulmonary impairment, not muscle injury, is associated with elevated ESR in the idiopathic inflammatory myopathies. Rheumatology (Oxford). 2013 Jul;52(7):1336-8. PMID: 23620561 Juraschek SP, Kovell LC, Miller ER, Gelber AC. Dose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout. PLoS One. 2013;8(2):e56546. PMID: 23460805 Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC. Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010. Semin Arthritis Rheum. 2013 Jun;42(6):551-61. PMID: 23312548

推荐链接
down
wechat
bug